These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8255476)

  • 1. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis.
    Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
    Neurology; 1993 Dec; 43(12):2679-82. PubMed ID: 8255476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.
    Khoury SJ; Orav EJ; Guttmann CR; Kikinis R; Jolesz FA; Weiner HL
    Neurology; 1999 Sep; 53(4):758-64. PubMed ID: 10489037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
    Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
    Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1994 Jun; 52(1):33-40. PubMed ID: 8207119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
    Patzold T; Sindern E; Ossege-Pohle L; Malin JP
    J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis.
    Carrieri PB; Provitera V; Bruno R; Perrella M; Tartaglia G; Busto A; Perrella O
    Neurol Res; 1997 Dec; 19(6):599-600. PubMed ID: 9427959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
    Wipfler P; Heikkinen A; Harrer A; Pilz G; Kunz A; Golaszewski SM; Reuss R; Oschmann P; Kraus J
    J Neurol; 2013 Jan; 260(1):221-7. PubMed ID: 22875099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble intercellular adhesion molecule-1 (ICAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1), and tumor necrosis factor receptor (55 kDa TNF-R) in patients with acute Plasmodium falciparum malaria.
    Wenisch C; Varijanonta S; Looareesuwan S; Graninger W; Pichler R; Wernsdorfer W
    Clin Immunol Immunopathol; 1994 Jun; 71(3):344-8. PubMed ID: 7515338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
    Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
    Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
    Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
    Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
    Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E
    J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.
    Kraus J; Oschmann P; Engelhardt B; Bauer R; Schiel C; Kern A; Stolz E; Traupe A; Dorndorf W
    Acta Neurol Scand; 2000 Feb; 101(2):135-9. PubMed ID: 10685862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of soluble ICAM-1 and TNFalphaR in the cerebrospinal fluid and serum levels in a population of Brazilian patients with relapsing-remitting multiple sclerosis.
    Alves-Leon SV; Batista E; Papais-Alvarenga R; Quírico-Santos T
    Arq Neuropsiquiatr; 2001 Mar; 59(1):18-22. PubMed ID: 11299425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
    Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
    Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone.
    Franciotta D; Piccolo G; Zardini E; Bergamaschi R; Cosi V
    Acta Neurol Scand; 1997 May; 95(5):275-9. PubMed ID: 9188901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1995 Jun; 59(1-2):35-40. PubMed ID: 7541057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial analysis of soluble intercellular adhesion molecule-1 level in relapsing-remitting multiple sclerosis patients during IFN-beta1b treatment.
    Kilinc M; Saatci-Cekirge I; Karabudak R
    J Interferon Cytokine Res; 2003 Mar; 23(3):127-33. PubMed ID: 12716484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-alpha and soluble adhesion molecules.
    Vora AJ; Kidd D; Miller DH; Perkin GD; Hughes RA; Ellis BA; Dumonde DC; Brown KA
    Mult Scler; 1997 Jun; 3(3):171-9. PubMed ID: 9310962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TNF-alpha and soluble TNF receptor p55 in patients wtih multiple sclerosis].
    Geppert A; Losy J
    Neurol Neurochir Pol; 1999; 33(4):807-14. PubMed ID: 10612095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.